Call us today 212-583-0100


Based on our LRP cell signaling modulation technology platform we have identified and are developing a number of active drug candidate compounds that indicate effectiveness for the treatment of type 2 diabetes.

Using genetic animal models and structural and computational biology we have been able to define some of the complex cellular machinery controlling glucose homeostasis, and we have synthesized novel entities that interact at key targets along the biochemical pathway.

Our first-in-class, proprietary orally-active molecules were shown to significantly lower blood glucose in standard animal models of diabetes.

Enzo continues to explore this very exciting line of research and to direct efforts toward the development of these potential therapies with novel mechanisms of action for the treatment of diabetes.